If you're an investor searching for the next big market winners, Wall Street analysts have zeroed in on one biotech stock ...
Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...
Scribe announced its initial research collaboration with Sanofi for CRISPR-based cell therapies to address oncology ...
The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...
Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.
And yet, data science is now poised to usher in a level and acceleration of progress that even life sciences have never ...
Broad coalition of world's greatest thinkers make urgent plea for 'moonshot' efforts to solve 'tragic mismatch of global food <a target=_blank hr ...
Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing ...
ON CRISPR enzyme, will combine with RNA guides for pharma customers. Deal follows HuidaGene agreement, offers 99% cost ...
A study published in Foresight demonstrates that Kognitic's neural network model significantly outperforms traditional methods in predicting primary completion dates (PCD) for clinical trials, ...
Morningstar, Inc. , a leading provider of independent investment insights, today introduced Direct Advisory Suite, a modern software application for financial advisors and investment professionals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback